The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia

被引:11
|
作者
Zafarani, Alireza [1 ]
Taghavi-Farahabadi, Mahsa [2 ]
Razizadeh, Mohammad Hossein [3 ]
Amirzargar, Mohammad Reza [1 ]
Mansouri, Mansoure [4 ]
Mahmoudi, Mohammad [5 ]
机构
[1] Iran Univ Med Sci, Fac Allied Med, Dept Hematol & Blood Banking, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[3] Iran Univ Med Sci, Fac Med, Dept Virol, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[5] Iran Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
关键词
NK cell; Exosomes; GVHD; GVL; Hematopoietic stem cell transplantation; Cytomegalovirus; NATURAL-KILLER-CELLS; MHC CLASS-I; KIR LIGAND INCOMPATIBILITY; EXPRESSING INHIBITORY KIR; ACUTE MYELOID-LEUKEMIA; T-CELL; MISSING-SELF; HAPLOIDENTICAL HSCT; INTERFERON-GAMMA; ACUTE GVHD;
D O I
10.1007/s12015-022-10449-2
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Natural killer (NK) cells are one of the innate immune cells that play an important role in preventing and controlling tumors and viral diseases, but their role in hematopoietic stem cell transplantation (HCT) is not yet fully understood. However, according to some research, these cells can prevent infections and tumor relapse without causing graft versus host disease (GVHD). In addition to NK cells, several studies are about the anti-leukemia effects of NK cell-derived exosomes that can highlight their roles in graft-versus-leukemia (GVL). In this paper, we intend to investigate the results of various articles on the role of NK cells in allogeneic hematopoietic cell transplantation and also their exosomes in GVL. Also, we have discussed the antiviral effects of these cells in post-HCT cytomegalovirus infection.
引用
收藏
页码:26 / 45
页数:20
相关论文
共 50 条
  • [31] Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
    Simonetta, Federico
    Alvarez, Maite
    Negrin, Robert S.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [32] Graft-versus-host disease
    Sauer, M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (11) : 1021 - +
  • [33] The Role of MicroRNA in Graft-Versus-Host-Disease: A Review
    Pitea, Martina
    Canale, Filippo Antonio
    Porto, Gaetana
    Verduci, Chiara
    Utano, Giovanna
    Policastro, Giorgia
    Alati, Caterina
    Santoro, Ludovica
    Imbalzano, Lucrezia
    Martino, Massimo
    GENES, 2023, 14 (09)
  • [34] Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
    Kelly, Kilian
    Rasko, John E. J.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [35] Graft versus Leukemia in 2023
    Chiad, Zane
    Chojecki, Aleksander
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (03)
  • [36] Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
    Huang, Ying
    Zou, Yujing
    Jiao, Yiqun
    Shi, Peijie
    Nie, Xiaoli
    Huang, Wei
    Xiong, Chuanfeng
    Choi, Michael
    Huang, Charles
    Macintyre, Andrew N.
    Nichols, Amanda
    Li, Fang
    Li, Chuan-Yuan
    MacIver, Nancie J.
    Cardona, Diana M.
    Brennan, Todd, V
    Li, Zhiguo
    Chao, Nelson J.
    Rathmell, Jeffrey C.
    Chen, Benny J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Rapid reconstitution of NK1 cells after allogeneic transplantation is associated with a reduced incidence of graft-versus-host disease
    Yu, Xingxing
    Xu, Lingling
    Chang, Yingjun
    Huang, Xiaojun
    Zhao, Xiangyu
    SCIENCE CHINA-LIFE SCIENCES, 2018, 61 (08) : 902 - 911
  • [38] Progress and prospects: graft-versus-host disease
    Mastaglio, S.
    Stanghellini, M. T. L.
    Bordignon, C.
    Bondanza, A.
    Ciceri, F.
    Bonini, C.
    GENE THERAPY, 2010, 17 (11) : 1309 - 1317
  • [39] The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review
    Berhan, Ayenew
    Damtie, Shewaneh
    Almaw, Andargachew
    Legesse, Biruk
    Sharew, Bekele
    Getie, Birhanu
    Erkihun, Mulat
    Solomon, Yenealem
    IMMUNOTARGETS AND THERAPY, 2024, 13 : 235 - 246
  • [40] Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects
    Ehx, Gregory
    Fransolet, Gilles
    de Leval, Laurence
    D'Hondt, Stephanie
    Lucas, Sophie
    Hannon, Muriel
    Delens, Loic
    Dubois, Sophie
    Drion, Pierre
    Beguin, Yves
    Humblet-Baron, Stephanie
    Baron, Frederic
    ONCOIMMUNOLOGY, 2017, 6 (05):